Hussman Strategic Advisors, Inc. Meridian Bioscience Inc Transaction History

Hussman Strategic Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$30.9 - $33.55 $478,950 - $520,024	-15,500 Reduced 25.0%	46,500 $1.47 Million
Q2 2022 Sep 12, 2022	BUY	$23.75 - $31.69 $1.47 Million - $1.96 Million	62,000 New	62,000 $1.89 Million
Q4 2021 Jan 31, 2022	SELL	$17.46 - $21.61 $2.51 Million - $3.11 Million	-144,000 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$19.76 - $29.89 $316,160 - $478,240	16,000 Added 12.5%	144,000 $3.78 Million
Q4 2020 Feb 01, 2021	BUY	$15.73 - $21.66 $1.21 Million - $1.67 Million	77,000 Added 150.98%	128,000 $2.39 Million
Q3 2020 Nov 02, 2020	BUY	$13.54 - $26.41 $690,540 - $1.35 Million	51,000 New	51,000 $866,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.